163 related articles for article (PubMed ID: 19726547)
1. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
Daniel C; Wagner A; Hohenstein B; Hugo C
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
[TBL] [Abstract][Full Text] [Related]
2. Glomerular activin A overexpression is linked to fibrosis in anti-Thy1 glomerulonephritis.
Gaedeke J; Boehler T; Budde K; Neumayer HH; Peters H
Nephrol Dial Transplant; 2005 Feb; 20(2):319-28. PubMed ID: 15673690
[TBL] [Abstract][Full Text] [Related]
3. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis.
Tsuda H; Yamahara K; Ishikane S; Otani K; Nakamura A; Sawai K; Ichimaru N; Sada M; Taguchi A; Hosoda H; Tsuji M; Kawachi H; Horio M; Isaka Y; Kangawa K; Takahara S; Ikeda T
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1004-13. PubMed ID: 20739390
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-beta 1 in experimental glomerulonephritis.
Border WA; Okuda S; Nakamura T; Languino LR; Ruoslahti E
Ciba Found Symp; 1991; 157():178-89; discussion 189-93. PubMed ID: 2070683
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
6. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
7. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.
Daniel C; Vogelbacher R; Stief A; Grigo C; Hugo C
PLoS One; 2013; 8(12):e83846. PubMed ID: 24376766
[TBL] [Abstract][Full Text] [Related]
8. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Huijun W; Long C; Zhigang Z; Feng J; Muyi G
Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
[TBL] [Abstract][Full Text] [Related]
10. The effect of transforming growth factor beta 1 on mesangial cell fibronectin synthesis: increased incorporation into the extracellular matrix and reduced pI but no effect on alternative splicing.
McKay NG; Khong TF; Haites NE; Power DA
Exp Mol Pathol; 1993 Dec; 59(3):211-24. PubMed ID: 8137903
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice.
Daniel C; Amann K; Hohenstein B; Bornstein P; Hugo C
J Am Soc Nephrol; 2007 Mar; 18(3):788-98. PubMed ID: 17287428
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
14. PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wittmann S; Hugo C
Nephrol Dial Transplant; 2008 Nov; 23(11):3427-36. PubMed ID: 18596129
[TBL] [Abstract][Full Text] [Related]
15. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
Daniel C; Wiede J; Krutzsch HC; Ribeiro SM; Roberts DD; Murphy-Ullrich JE; Hugo C
Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
[TBL] [Abstract][Full Text] [Related]
17. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
19. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
20. In vivo transfer of engineered macrophages into the glomerulus: endogenous TGF-beta-mediated defense against macrophage-induced glomerular cell activation.
Sütö TS; Fine LG; Shimizu F; Kitamura M
J Immunol; 1997 Sep; 159(5):2476-83. PubMed ID: 9278341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
